Download PDF
Thromb Haemost 2005; 94(04): 895-896
DOI: 10.1055/s-0037-1615587
Letters to the Editor
Schattauer GmbH

Hypersensitivity to the pentasaccharide fondaparinux in patients with delayed-type heparin allergy

Jochen Utikal
1   Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl-University of Heidelberg, Mannheim, Germany
,
Wiebke K. Peitsch
1   Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl-University of Heidelberg, Mannheim, Germany
,
Dirk Booken
1   Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl-University of Heidelberg, Mannheim, Germany
,
Florian Velten
1   Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl-University of Heidelberg, Mannheim, Germany
,
Carl-Erik Dempfle
2   Department of Medicine I, University Medical Center Mannheim, Ruprecht-Karl-University of Heidelberg, Mannheim, Germany
,
Sergij Goerdt
1   Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl-University of Heidelberg, Mannheim, Germany
,
Christiane Bayerl
1   Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl-University of Heidelberg, Mannheim, Germany
› Author Affiliations
Further Information

Publication History

Received09 May 2005

Accepted after resubmission01 August 2005

Publication Date:
11 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Estrada Rodriguez JL, Gozalo Reques F, Ortiz de Urbina J. et al. Generalized eczema induced by nadroparin. J Investig Allergol Clin Immunol 2003; 13: 6970.
    PubMedGoogle Scholar
  • 2 Bussey H, Francis JL. Heparin Consensus Group. Heparin overview and issues. Pharmacotherapy 2004; 24: 103S-107S.
    CrossrefPubMedGoogle Scholar
  • 3 Parody R, Oliver A, Souto JC. et al. Fondaparinux (Arixtra) as an alternative anti-thrombotic prophylaxis when there is hypersensitivity to low molecular weight and unfractionated heparins. Haematologica 2003; 88: ECR32.
    PubMedGoogle Scholar
  • 4 Sacher C, Hunzelmann N. Tolerance to the synthetic pentasaccharide fondaparinux in heparin sensitization. Allergy 2003; 58: 1318-9.
    CrossrefPubMedGoogle Scholar
  • 5 Ludwig RJ, Beier C, Lindhoff-Last E. et al. Tolerance of fondaparinux in a patient allergic to heparins and other glycosaminoglycans. Contact Dermatitis 2003; 49: 158-9.
    CrossrefPubMedGoogle Scholar
  • 6 Maetzke J, Hinrichs R, Staib G. et al. Fondaparinux as a novel therapeutic alternative in a patient with heparin allergy. Allergy 2004; 59: 237-8.
    CrossrefPubMedGoogle Scholar
  • 7 Koch P. Delayed-type hypersensitivity skin reactions due to heparins and heparinoids. Tolerance of recombinant hirudins and of the new synthetic anticoagulant fondaparinux. Contact Dermatitis 2003; 49: 276-80.
    CrossrefPubMedGoogle Scholar
  • 8 Jappe U, Juschka U, Kuner N. et al. Fondaparinux: a suitable alternative in cases of delayed-type allergy to heparins and semisynthetic heparinoids? A study of 7 cases. Contact Dermatitis 2004; 51: 67-72.
    CrossrefPubMedGoogle Scholar
  • 9 Borch JE, Bindslev-Jensen C. Delayed-type hypersensitivity to heparins. Allergy 2004; 59: 118-9.
    CrossrefPubMedGoogle Scholar
  • 10 Hirsch K, Ludwig RJ, Lindhoff-Last E. et al. Intolerance of fondaparinux in a patient allergic to heparins. Contact Dermatitis 2004; 50: 383-4.
    CrossrefPubMedGoogle Scholar
  • 11 Hohenstein E, Tsakiris D, Bircher AJ. Delayed-type hypersensitivity to the ultra-low-molecular-weight heparin fondaparinux. Contact Dermatitis 2004; 51: 149-51.
    CrossrefPubMedGoogle Scholar
  • 12 Maetzke J, Hinrichs R, Schneider LA. et al. Unexpected delayed-type hypersensitivity skin reactions to the ultra-low-molecular-weight heparin fondaparinux. Allergy 2005; 60: 413-5.
    CrossrefPubMedGoogle Scholar
  • 13 Badger NO, Butler K, Hallman LC. Excessive anticoagulation and anaphylactic reaction after rechallenge with lepirudin in a patient with heparin-induced thrombocytopenia. Pharmacotherapy 2004; 24: 1800-3.
    CrossrefPubMedGoogle Scholar
  • 14 Grassegger A, Fritsch P, Reider N. Delayed-type hypersensitity and cross-reavtivity to heparins and danaparoid: a prospective study. Dermatol Surg 2001; 27: 4752.
    PubMedGoogle Scholar
  • 15 Gaigl Z, Pfeuffer P, Raith P. et al. Tolerance to intravenous heparin in patients with delayed-type hypersensitivity to heparins: a prospective study. Br J Haematol 2005; 128: 389-92.
    CrossrefPubMedGoogle Scholar